
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    This is an excellent task that requires a systematic approach to single-cell type annotation. I will proceed step-by-step to provide a comprehensive analysis of the provided marker list from a human large intestine scRNA-seq dataset.<br><br>**Step 1: List the Key Functional Markers**<br><br>The provided list is overwhelmingly enriched with genes involved in cell cycle progression, DNA replication, and mitosis.<br><br>*   **Cell Cycle Regulation & DNA Replication:**<br>    *   **MCM10, MCM2:** Members of the Minichromosome Maintenance (MCM) complex, essential for DNA replication initiation and elongation. MCM2-7 form the core helicase.<br>    *   **GINS1:** Part of the GINS complex, which is crucial for DNA replication fork progression.<br>    *   **RRM2:** Ribonucleotide Reductase M2, catalyzes the rate-limiting step in dNTP synthesis, essential for DNA replication.<br>    *   **TYMS:** Thymidylate Synthase, involved in dTMP synthesis, crucial for DNA replication and repair.<br>    *   **TIMELESS:** Involved in DNA replication fork stability and checkpoint control.<br>    *   **XRCC2:** X-ray Repair Cross Complementing 2, involved in homologous recombination repair of DNA double-strand breaks, often active during S/G2 phases.<br>    *   **DSCC1:** DNA replication and sister chromatid cohesion 1, involved in sister chromatid cohesion.<br>    *   **ESCO2:** Establishment of Sister Chromatid Cohesion N-Acetyltransferase 2, crucial for sister chromatid cohesion.<br>    *   **HELLS:** Helicase, Lymphoid Specific, involved in chromatin remodeling and DNA replication.<br>    *   **E2F8:** E2F Transcription Factor 8, a key regulator of cell cycle progression, particularly G1/S transition and DNA replication.<br>    *   **CCNA2:** Cyclin A2, a key cyclin involved in both S phase progression and G2/M transition.<br><br>*   **Mitosis & Cytokinesis:**<br>    *   **CKAP2L (Cytoskeleton Associated Protein 2 Like):** Involved in microtubule organization and cell division.<br>    *   **SKA1 (Spindle and Kinetochore Associated 1):** Component of the Ska complex, essential for stable kinetochore-microtubule attachment during mitosis.<br>    *   **NEK2 (NIMA Related Kinase 2):** Involved in centrosome separation and spindle formation.<br>    *   **BUB1 (BUB1 Mitotic Checkpoint Serine/Threonine Kinase):** Key component of the spindle assembly checkpoint (SAC), ensuring proper chromosome segregation.<br>    *   **CDCA2 (Cell Division Cycle Associated 2):** Involved in mitotic progression.<br>    *   **CENPA (Centromere Protein A):** A histone H3 variant specific to centromeres, crucial for kinetochore assembly.<br>    *   **CDC25C (Cell Division Cycle 25C):** A phosphatase that activates CDK1, promoting entry into mitosis.<br>    *   **OIP5 (OPA-Interacting Protein 5):** Involved in kinetochore function and mitotic progression.<br>    *   **DLGAP5 (DLG Associated Protein 5):** Involved in spindle organization and mitotic progression.<br>    *   **CEP55 (Centrosomal Protein 55):** Involved in cytokinesis.<br>    *   **KIF4A (Kinesin Family Member 4A):** A kinesin motor protein involved in chromosome segregation and cytokinesis.<br>    *   **TK1 (Thymidine Kinase 1):** Involved in DNA synthesis, highly expressed in proliferating cells.<br>    *   **PCLAF (PCNA-Associated Factor):** Involved in DNA replication and repair, often associated with proliferation.<br>    *   **GTSE1 (G2 and S-Phase Expressed 1):** Involved in mitotic spindle organization.<br>    *   **KIF2C (Kinesin Family Member 2C):** A kinesin motor protein involved in chromosome congression and anaphase.<br>    *   **CENPW (Centromere Protein W):** Component of the CENP-T-W complex, essential for kinetochore assembly.<br>    *   **NDC80 (NDC80 Kinetochore Complex Component):** Core component of the NDC80 complex, crucial for kinetochore-microtubule attachment.<br>    *   **MELK (Maternal Embryonic Leucine Zipper Kinase):** Involved in cell cycle progression, mitosis, and cytokinesis.<br>    *   **MND1 (Meiotic Nuclear Division 1 Homolog):** Involved in homologous recombination and DNA repair, often active during proliferation.<br>    *   **NUF2 (NUF2 Kinetochore Complex Component):** Component of the NDC80 complex.<br>    *   **POC1A (Protein Of Centriole 1A):** Involved in centriole biogenesis.<br>    *   **DEPDC1 (DEP Domain Containing 1):** Involved in cell cycle progression and proliferation.<br>    *   **CDCA3 (Cell Division Cycle Associated 3):** Involved in mitotic progression.<br>    *   **CDCA8 (Cell Division Cycle Associated 8):** Component of the Borealin-Dasra complex, essential for chromosome segregation.<br>    *   **PRC1 (Protein Regulator Of Cytokinesis 1):** Involved in cytokinesis and spindle midzone formation.<br>    *   **KIFC1 (Kinesin Family Member C1):** A kinesin motor protein involved in spindle organization.<br>    *   **PBK (PDZ Binding Kinase):** Involved in cell cycle progression and mitosis.<br>    *   **HMMR (Hyaluronan Mediated Motility Receptor):** Involved in spindle assembly and chromosome segregation.<br>    *   **DIAPH3 (Diaphanous Related Formin 3):** Involved in actin cytoskeleton organization and cytokinesis.<br>    *   **LMNB1 (Lamin B1):** A nuclear lamina protein, its expression can be associated with cell proliferation.<br>    *   **UBE2T (Ubiquitin Conjugating Enzyme E2 T):** Involved in DNA repair and cell cycle progression.<br>    *   **MAD2L1 (Mitotic Arrest Deficient 2 Like 1):** Key component of the spindle assembly checkpoint (SAC).<br>    *   **PKMYT1 (Protein Kinase, Myosin Light Chain Kinase Related):** Involved in mitotic entry.<br>    *   **SPC24 (SPC24 Kinetochore Complex Component):** Component of the NDC80 complex.<br>    *   **IQGAP3 (IQ Motif And GTPase Activating Protein 3):** Involved in cell proliferation and migration.<br><br>*   **Other Proliferation-Associated Markers:**<br>    *   **PIMREG (PIM Kinase Regulatory Subunit):** Involved in cell proliferation and survival.<br>    *   **SHCBP1 (SHC Binding And Spindle Associated 1):** Involved in cell proliferation and spindle organization.<br>    *   **MTFR2 (Mitochondrial Fission Regulator 2):** While primarily mitochondrial, its expression can be linked to metabolic demands of proliferating cells.<br><br>**Summary of Functional Markers:** The overwhelming majority of the listed markers are directly and strongly associated with active cell division, including DNA replication (S phase) and mitosis (M phase). This indicates a highly proliferative cell population.<br><br>**Step 2: List the Key Cell Type Markers**<br><br>Given the provided list, there are no specific markers that definitively point to a *differentiated* cell type within the large intestine (e.g., enterocytes, goblet cells, Paneth cells, immune cells, fibroblasts, etc.). Instead, the markers are generic indicators of proliferation.<br><br>*   **No specific large intestine lineage markers:** Genes like *MUC2* (goblet cells), *FABP1/2* (enterocytes), *CHGA/B* (enteroendocrine cells), *CD3D/E* (T cells), *CD19/MS4A1* (B cells), *EPCAM* (epithelial cells), *VIM* (fibroblasts), *ACTA2* (smooth muscle cells), or *LGR5* (stem cells) are absent.<br><br>**Summary of Cell Type Markers:** The list lacks specific markers for terminally differentiated cell types of the large intestine. The markers are universally associated with cell proliferation.<br><br>**Step 3: Cross-reference Known Databases**<br><br>Cross-referencing these markers with scRNA-seq databases (e.g., Human Cell Atlas, Tabula Sapiens, specific large intestine atlases like those from the Gut Cell Atlas consortium) consistently shows that these genes are highly expressed in:<br><br>*   **Proliferating cells:** This is the most consistent finding.<br>*   **Stem cells/Progenitor cells:** These populations are inherently proliferative.<br>*   **Cancer cells:** Many of these genes are upregulated in various cancers due to uncontrolled proliferation.<br>*   **Specific cell cycle phases:** Many are specifically expressed in S, G2, or M phases.<br><br>For example, searching for "CKAP2L" or "SKA1" in large intestine scRNA-seq datasets typically highlights clusters annotated as "proliferating epithelial cells," "crypt base columnar cells (CBCs)," or "transit-amplifying (TA) cells."<br><br>**Step 4: Determine the Most Probable General Cell Type**<br><br>Based on the overwhelming enrichment of cell cycle, DNA replication, and mitotic genes, the most probable general cell type is **Proliferating Cells**.<br><br>In the context of the large intestine, this strongly points towards the epithelial lineage, specifically the stem and progenitor compartments within the crypts.<br><br>**Step 5: Identify the Top 3 Most Probable Sub Cell Types**<br><br>Considering the large intestine context and the highly proliferative nature indicated by the markers:<br><br>1.  **Most Likely: Transit-Amplifying (TA) Cells (or Proliferating Epithelial Cells)**<br>    *   **Reasoning:** TA cells are highly proliferative cells located in the intestinal crypts, just above the stem cell zone. They undergo rapid division to produce the vast majority of differentiated epithelial cells (enterocytes, goblet cells, enteroendocrine cells, Paneth cells). The sheer number and high expression of cell cycle genes are characteristic of these rapidly dividing populations. The markers provided are a textbook signature of cells actively undergoing the cell cycle.<br><br>2.  **Second Most Likely: Crypt Base Columnar (CBC) Stem Cells**<br>    *   **Reasoning:** CBC stem cells (Lgr5+ stem cells) are the primary stem cells of the intestinal epithelium, located at the very bottom of the crypts. They are also highly proliferative, self-renewing, and give rise to TA cells. While they are proliferative, TA cells typically exhibit an even higher rate of division and thus often show a stronger and more uniform expression of cell cycle genes across the population. However, CBCs would certainly express these markers.<br><br>3.  **Third Most Likely: Proliferating Immune Cells (e.g., Activated T cells, B cells)**<br>    *   **Reasoning:** While less likely to be the *primary* identity given the sheer number of general cell cycle markers without any specific immune lineage markers, immune cells can proliferate rapidly in response to activation or inflammation. Lymphocytes (T and B cells) undergo clonal expansion, and myeloid cells can also proliferate. However, without specific immune markers (e.g., CD3, CD8, CD4, CD19, CD68, etc.), this is a less specific and less probable primary annotation compared to the epithelial proliferative populations in the intestine. The markers are too generic for proliferation to pinpoint an immune cell type without additional evidence.<br><br>**Most Likely Subtype:** Based on the comprehensive and strong expression of a wide array of cell cycle and mitotic genes, the most likely subtype is **Transit-Amplifying (TA) Cells**. These cells are characterized by their rapid and extensive proliferation to generate the differentiated cells of the intestinal epithelium.<br><br>**Step 6: Provide a Concise Summary of Your Analysis**<br><br>The provided marker list is overwhelmingly dominated by genes directly involved in DNA replication, cell cycle progression, and mitosis (e.g., MCM10, RRM2, TYMS, CCNA2, BUB1, KIF4A, NDC80, PRC1). This signature unequivocally indicates a highly proliferative cell population. In the context of the human large intestine, such a strong proliferative signature is characteristic of the epithelial lineage within the crypts. Cross-referencing with scRNA-seq databases confirms these markers as hallmarks of dividing cells. Therefore, the general cell type is **Proliferating Cells**. Within the large intestine, the most probable specific subtype is **Transit-Amplifying (TA) Cells**, which are known for their rapid division to replenish the intestinal epithelium. Crypt Base Columnar (CBC) Stem Cells are also highly proliferative and would express these markers, but TA cells typically represent the bulk of the actively dividing population. Proliferating immune cells are a less likely candidate without specific immune lineage markers.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Proliferating Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Transit-Amplifying (TA) Cells</li><li>Crypt Base Columnar (CBC) Stem Cells</li><li>Proliferating Immune Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">98</div>
                        <div class="scoring-content">
                            The annotation provided is exceptionally thorough and accurate, demonstrating a deep understanding of single-cell biology and the context of the human large intestine.<br><br>**Strengths:**<br><br>1.  **Comprehensive Marker Analysis:** The agent meticulously broke down the entire list of 50 markers, categorizing them by function (DNA replication, mitosis, other proliferation-associated). This systematic approach ensures that no marker is overlooked and their collective meaning is accurately interpreted.<br>2.  **Accurate Functional Grouping:** The grouping of markers into "Cell Cycle Regulation & DNA Replication" and "Mitosis & Cytokinesis" is spot-on. The explanations for each gene's role are concise and scientifically correct (e.g., MCM10/MCM2 for replication, BUB1 for SAC, KIF4A for chromosome segregation).<br>3.  **Strong Interpretation of Overwhelming Signal:** The agent correctly identified the "overwhelming enrichment" of cell cycle and proliferation-related genes. This is the most crucial insight from the marker list, and it was highlighted effectively.<br>4.  **Contextual Awareness (Human Large Intestine):** The annotation expertly leveraged the "human large intestine" origin. This allowed for highly specific and relevant sub-cell type predictions (Transit-Amplifying cells, CBC Stem Cells) that would not be possible without this contextual information.<br>5.  **Database Cross-referencing:** The mention of cross-referencing with scRNA-seq databases (Human Cell Atlas, Tabula Sapiens) adds significant weight to the analysis, indicating a data-driven approach to validation. The examples of "proliferating epithelial cells," "crypt base columnar cells (CBCs)," or "transit-amplifying (TA) cells" are perfectly aligned with expected findings in intestinal scRNA-seq.<br>6.  **Logical Step-by-Step Approach:** The "Step 1" through "Step 6" structure is clear, logical, and easy to follow, mirroring a robust annotation workflow.<br>7.  **Consideration of "No Specific Cell Type Markers":** The agent correctly noted the *absence* of specific differentiated large intestine markers, which reinforces the conclusion that the cluster represents a proliferative state rather than a terminally differentiated cell type. This demonstrates a balanced view and avoids forcing an annotation where one doesn't fit.<br>8.  **Prioritization of Sub-Cell Types:** The ranking of "Transit-Amplifying (TA) Cells" as most likely, followed by "CBC Stem Cells," and then "Proliferating Immune Cells," is well-justified. The reasoning for each choice (e.g., TA cells' rapid division rate vs. CBCs, lack of immune-specific markers for immune cells) is sound.<br>9.  **Addressing Marker Rank:** Although not explicitly stated as a "rule" in the prompt, the agent implicitly considered the collective weight of *all* markers rather than over-focusing on the first few. The consistency across the entire list, regardless of order, points to the same conclusion, which is a strong indicator of a robust signal. The prompt states "marker appear first is more important" however, in this case, the entire list is so overwhelmingly proliferative that the specific order of these highly correlated genes becomes less critical than their sheer number and consistency. The agent's focus on the "overwhelming enrichment" rather than just the top few is appropriate here.<br><br>**Weaknesses:**<br><br>1.  **Minor Redundancy in Marker Explanation:** Some markers are explained very similarly (e.g., multiple kinetochore components or kinesins). While accurate, a slightly more concise grouping after the initial detailed breakdown might improve readability, but this is a very minor point given the overall quality.<br><br>**Overall Picture:**<br><br>The annotation successfully captures the general picture of the data: a highly proliferative cell population. It goes beyond this general picture to accurately pinpoint the most probable specific cell types within the large intestine context. The analysis is scientifically accurate, comprehensive, and well-reasoned. It demonstrates an expert-level understanding of single-cell data interpretation.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    